Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shaozhuo Huang
Observed names:
Shao-Zhuo Huang,
Shao-zhuo Huang,
Shao‐Zhuo Huang
Institution:
Erasmus MC
Observed institutions:
Sun Yat-sen University,
Erasmus MC,
Nanfang Hospital,
Third Affiliated Hospital of Sun Yat-sen University,
Erasmus MC Cancer Institute,
Southern Medical University
show all 6
ORCID:
0000-0001-9272-2497
Observed ORCID:
0000-0001-9272-2497
OpenAlex ID:
A5027090919
Risk of skin cancers in thiopurines‐treated and thiopurines‐untreated patients with inflammatory bowel disease: A systematic review and meta‐analysis
2018
·
Shao‐Zhuo Huang
, Zhi‐Cheng Liu
, et al.
·
Journal of Gastroenterology and Hepatology
·
64
Prognostic and immunological role of CD36: A pan-cancer analysis
2021
·
Yong-Jian Chen
, Wei-Xin Liao
, et al.
·
Journal of Cancer
·
39
PDF
Norcholic Acid Promotes Tumor Progression and Immune Escape by Regulating Farnesoid X Receptor in Hepatocellular Carcinoma
2021
·
Yihang Gong
, Kun Li
, et al.
·
Frontiers in Oncology
·
37
PDF
MRI radiomic features of peritumoral edema may predict the recurrence sites of glioblastoma multiforme
2023
·
Hao Long
, Ping Zhang
, et al.
·
Frontiers in Oncology
·
35
PDF
CD8+CD28+/CD8+CD28− T cell equilibrium can predict the active stage for patients with inflammatory bowel disease
2017
·
Shi-xue Dai
, Hong-xiang Gu
, et al.
·
Clinics and Research in Hepatology and Gastroenterology
·
27
Risk of Lymphoma in Patients With Inflammatory Bowel Disease Treated With Anti-tumour Necrosis Factor Alpha Agents: A Systematic Review and Meta-analysis
2018
·
Chen Yang
, Junlin Huang
, et al.
·
Journal of Crohn s and Colitis
·
25
Comparison of emergency cholecystectomy and delayed cholecystectomy after percutaneous transhepatic gallbladder drainage in patients with acute cholecystitis: a systematic review and meta-analysis
2020
·
Shao-Zhuo Huang
, Hao-Qi Chen
, et al.
·
Updates in Surgery
·
23
PDF
Comprehensive Analysis of ANLN in Human Tumors: A Prognostic Biomarker Associated with Cancer Immunity
2022
·
Xiaoyu Zhang
, Lin Li
, et al.
·
Oxidative Medicine and Cellular Longevity
·
17
PDF
The prognostic role of pretreatment thrombocytosis in gastric cancer
2018
·
Chen Yang
, Hui Jiang
, et al.
·
Medicine
·
16
TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
2024
·
Dian Kortleve
, Dora Hammerl
, et al.
·
Cancer Discovery
·
14
Nomograms for predicting the overall and cancer-specific survival of patients with high-grade glioma: a surveillance, epidemiology, and end results study.
2019
·
Yuhan Xia
, Weixin Liao
, et al.
·
Turkish Neurosurgery
·
13
Decreased CD8+CD28+/CD8+CD28– T cell ratio can sensitively predict poor outcome for patients with complicated Crohn disease
2017
·
Shi-xue Dai
, Hong-xiang Gu
, et al.
·
Medicine
·
12
Dynactin 2 acts as an oncogene in hepatocellular carcinoma through promoting cell cycle progression
2022
·
Wenchao Li
, Jiehuan Chen
, et al.
·
Liver Research
·
9
PDF
Pan-Cancer Landscape of NEIL3 in Tumor Microenvironment: A Promising Predictor for Chemotherapy and Immunotherapy
2022
·
Weixin Liao
, Shaozhuo Huang
, et al.
·
Cancers
·
6
Targeting cellular senescence as a therapeutic vulnerability in gastric cancer
2024
·
Haigang Geng
, Chen Huang
, et al.
·
Life Sciences
·
5
Safety and feasibility of single-incision radical vulvectomy: a novel approach for the treatment of vulvar cancer
2021
·
Liqing He
, Gaowen Chen
, et al.
·
Annals of Translational Medicine
·
5
PDF
Tumor-intrinsic Ist1 restricts IFNγ responsiveness to drive immune evasion in pancreatic cancer
2026
·
Weixin Liao
, Shaozhuo Huang
, et al.
·
Research Square
PDF
Supplementary Figure 2 from TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
2026
·
Dian Kortleve
, Dora Hammerl
, et al.
Supplementary Table 2 from TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
2026
·
Dian Kortleve
, Dora Hammerl
, et al.
Supplementary Figure 3 from TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
2026
·
Dian Kortleve
, Dora Hammerl
, et al.
Supplementary Figure 5 from TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
2026
·
Dian Kortleve
, Dora Hammerl
, et al.
Supplementary Figure 9 from TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
2026
·
Dian Kortleve
, Dora Hammerl
, et al.
Supplementary Figure 6 from TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
2026
·
Dian Kortleve
, Dora Hammerl
, et al.
Supplementary Figure 8 from TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
2026
·
Dian Kortleve
, Dora Hammerl
, et al.
Supplementary Figure 4 from TCR-Engineered T Cells Directed against Ropporin-1 Constitute a Safe and Effective Treatment for Triple-Negative Breast Cancer
2026
·
Dian Kortleve
, Dora Hammerl
, et al.
Show more works
View as search
Works count:
48
Citation count:
347
H-index:
12
I10-index:
12
Year
Topic
Type